H&R GmbH KGaA (LTS:0RRC) Debt-to-EBITDA : 1.55 (As of Mar. 2026) — 21% Below Median

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

LTS:0RRC H&R GmbH & Co KGaA LTS:0RRC
68 GF Score
Price €6.08
GF Value €4.15
Valuation Significantly Overvalued
! 6 Warning Signs
View Full Analysis

What is H&R GmbH KGaA Debt-to-EBITDA?

H&R GmbH KGaA LTS:0RRC -0.33% 68 Debt-to-EBITDA is 1.55 as of Mar. 2026, which is 21% below its 10-year median of 1.96. GuruFocus rates LTS:0RRC with a GF Score™ of 68/100 and a GF Value™ of €4.15 (Significantly Overvalued). The stock has 6 warning signs investors should review. Among 1,241 Chemicals companies, H&R GmbH KGaA ranks worse than 62.13% on this metric.

Debt-to-EBITDA measures a company's ability to pay off its debt.

H&R GmbH KGaA's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2026 was €119 Mil. H&R GmbH KGaA's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2026 was €17 Mil. H&R GmbH KGaA's annualized EBITDA for the quarter that ended in Mar. 2026 was €88 Mil. H&R GmbH KGaA's annualized Debt-to-EBITDA for the quarter that ended in Mar. 2026 was 1.55.

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

The historical rank and industry rank for H&R GmbH KGaA's Debt-to-EBITDA or its related term are showing as below:

LTS:0RRC' s Debt-to-EBITDA Range Over the Past 10 Years
Min: 0.94   Med: 1.96   Max: 4.37
Current: 3.13

During the past 13 years, the highest Debt-to-EBITDA Ratio of H&R GmbH KGaA was 4.37. The lowest was 0.94. And the median was 1.96.

LTS:0RRC's Debt-to-EBITDA is ranked worse than
62.13% of 1241 companies
in the Chemicals industry
Industry Median: 2.15 vs LTS:0RRC: 3.13

H&R GmbH KGaA  (LTS:0RRC) Debt-to-EBITDA Explanation

In the calculation of Debt-to-EBITDA, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by EBITDA. In some calculations, Total Liabilities is used to for calculation.


Be Aware

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.

According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.


H&R GmbH KGaA Debt-to-EBITDA Related Terms


H&R GmbH KGaA Debt-to-EBITDA Historical Data

* Premium members only.

The historical data trend for H&R GmbH KGaA's Debt-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

H&R GmbH KGaA Debt-to-EBITDA Chart

H&R GmbH KGaA Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Debt-to-EBITDA
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.48 1.96 1.76 2.12 4.17

H&R GmbH KGaA Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Debt-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.03 2.20 1.97 -2.71 1.55

LTS:0RRC vs LIN, SHW, ECL: Debt-to-EBITDA Comparison

For the Specialty Chemicals subindustry, H&R GmbH KGaA's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


H&R GmbH KGaA Debt-to-EBITDA vs Chemicals Industry

For the Chemicals industry and Basic Materials sector, H&R GmbH KGaA's Debt-to-EBITDA distribution charts can be found below:

* The bar in red indicates where H&R GmbH KGaA's Debt-to-EBITDA falls into.


LTS:0RRC
68GF Score
H&R GmbH & Co KGaA LTS:0RRC
Debt-to-EBITDA is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

H&R GmbH KGaA Debt-to-EBITDA Calculation

Debt-to-EBITDA measures a company's ability to pay off its debt.

H&R GmbH KGaA's Debt-to-EBITDA for the fiscal year that ended in Dec. 2025 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(134.793 + 48.299) / 43.865
=4.17

H&R GmbH KGaA's annualized Debt-to-EBITDA for the quarter that ended in Mar. 2026 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(118.63 + 17.433) / 88.02
=1.55

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data, the EBITDA data used here is four times the quarterly (Mar. 2026) EBITDA data.

Frequently Asked Questions Learn more about Debt-to-EBITDA →
What does a Debt-to-EBITDA of 1.55 mean?
H&R GmbH KGaA (LTS:0RRC) has a Debt-to-EBITDA of 1.55 as of Mar. 2026. Debt-to-EBITDA ratio represents the ratio of total debt to total earnings before interest, taxes, depreciation and amortization. View historical data on H&R GmbH KGaA. This is 21% below median its historical median of 1.96. Over the past decade, H&R GmbH KGaA's Debt-to-EBITDA has ranged from 0.94 to 4.37. According to the industry distribution chart, H&R GmbH KGaA ranks #771 out of 1241 companies in the Chemicals industry, placing it in the top 62.1%.
Is H&R GmbH KGaA's Debt-to-EBITDA too high?
H&R GmbH KGaA's current Debt-to-EBITDA of 1.55 is 21% below median its 10-year median of 1.96. Over the past 10 years, this metric has ranged from a low of 0.94 to a high of 4.37. The Chemicals industry median Debt-to-EBITDA is 2.15. H&R GmbH KGaA's value of 1.55 is 27.9% below this industry median. Based on the distribution chart, H&R GmbH KGaA ranks #771 out of 1241 companies in the Chemicals industry, which is below the industry midpoint. Overall, H&R GmbH KGaA has a GF Score™ of 68/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does H&R GmbH KGaA's Debt-to-EBITDA compare to LIN and SHW?
According to the Chemicals industry distribution chart, H&R GmbH KGaA ranks #771 out of 1241 companies for Debt-to-EBITDA. This places H&R GmbH KGaA in the lower half of its industry. The industry median Debt-to-EBITDA is 2.15. H&R GmbH KGaA's value of 1.55 is 27.9% below this benchmark. Historically, H&R GmbH KGaA's own Debt-to-EBITDA has ranged from 0.94 to 4.37 over the past decade. While the company's 10-year median is 1.96 vs. the industry median of 2.15, H&R GmbH KGaA has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Debt-to-EBITDA for a Chemicals company?
The median Debt-to-EBITDA among Chemicals companies is 2.15, based on 1,241 companies in the industry. Companies in the top quartile (top 25%) have a Debt-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, Debt-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. H&R GmbH KGaA's current Debt-to-EBITDA of 1.55 is 27.9% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Debt-to-EBITDA mean?
A high Debt-to-EBITDA can signal that a stock is expensive relative to its fundamentals. Debt-to-EBITDA ratio represents the ratio of total debt to total earnings before interest, taxes, depreciation and amortization. View historical data on H&R GmbH KGaA. For the Chemicals industry, the median Debt-to-EBITDA is 2.15 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. H&R GmbH KGaA's current Debt-to-EBITDA is 1.55, which is 21% below median its own 10-year median of 1.96. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is H&R GmbH KGaA stock overvalued right now?
Based on GuruFocus' analysis, H&R GmbH KGaA (LTS:0RRC) is currently considered Significantly Overvalued. The stock's GF Value™ is €4.15, compared to a current price of €6.08 — trading 46.5% above its estimated fair value. The current Debt-to-EBITDA is 1.55, which is 21% below median its 10-year median of 1.96 and 27.9% below the Chemicals industry median of 2.15. H&R GmbH KGaA's overall GF Score™ is 68/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Debt-to-EBITDA calculated?
Debt-to-EBITDA is calculated from a company's financial statements. For H&R GmbH KGaA (LTS:0RRC), the current Debt-to-EBITDA is 1.55 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is H&R GmbH KGaA (LTS:0RRC) Overvalued in 2026?

Based on GuruFocus' analysis, H&R GmbH KGaA stock appears to be overvalued. The current stock price of €6.08 is trading 46.5% above its estimated GF Value™ of €4.15. GuruFocus considers H&R GmbH KGaA to be Significantly Overvalued.

Key valuation signals for LTS:0RRC:

  • Debt-to-EBITDA: 1.55 (21% below median its 10-year median of 1.96)
  • GF Value™: €4.15 vs. price of €6.08 (46.5% above fair value)
  • GF Score™: 68/100 with 6 warning signs
  • Industry Position: 27.9% below the Chemicals median (#771 of 1241)

No single metric tells the full story. See the LTS:0RRC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


H&R GmbH KGaA Business Description

Other Exchanges 2HRA:Germany2HRA:Austria
Address Neuenkirchener Strasse 8, Salzbergen, NI, DEU, 48499
H&R GmbH & Co KGaA is a manufacturer of chemical-pharmaceutical specialty products. The company organizes its operating activities into two business divisions: Chemical-Pharmaceutical Raw Materials and Plastics. It also has three business segments: ChemPharm Refining, ChemPharm Sales, and Plastics. The ChemPharm Refining segment produces specialty products from crude oil in the two domestic refineries (Hamburg-Neuhof and Salzbergen). Its ChemPharm Sales segment encompasses the production sites abroad as well as international sales activities. The company's Plastics segment manufactures high-precision plastic parts along with the associated tools and molds. The company derives a majority of its revenue from the ChemPharm Refining segment. Geographically, it derives key revenue from Germany.
68GF Score

Get the complete analysis for LTS:0RRC

Debt-to-EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€6.08
Price
€4.15
GF Value